Therefore, the diminished binding of EBF1 to the MEF2C promoter resulted in heightened MEF2C transcription within cardiomyocytes, thereby contributing to the development of cardiac hypertrophy (Figure 7M). The gene discussed is EBF1; the disease is cardiac hypertrophy.